Search Results for "drug"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for drug. Results 611 to 612 of 612 total matches.
COVID-19 Update: Novavax Vaccine for 2024-2025
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024 (Issue 1714)
formulations
for 2024-2025. Med Lett Drugs Ther 2024; 66:151.
4. COVID-19 Real-Time Learning Network. COVID ...
A 2024-2025 formulation of the Novavax adjuvanted
protein subunit COVID-19 vaccine that more
closely targets currently circulating SARS-CoV-2
variants is available now under an FDA Emergency
Use Authorization (EUA) for use in persons ≥12
years old. The 2024-2025 formulations of the
mRNA COVID-19 vaccines manufactured by Pfizer/BioNTech (Comirnaty) and Moderna (Spikevax) were licensed by the FDA last month for use in persons ≥12
years old and made available under EUAs for use in
persons 6 months to 11 years old.
Med Lett Drugs Ther. 2024 Oct 28;66(1714):175-6 doi:10.58347/tml.2024.1714d | Show Introduction Hide Introduction
Shield — A Blood Test for Colorectal Cancer Screening
The Medical Letter on Drugs and Therapeutics • Jun 09, 2025 (Issue 1730)
– an at-home stool DNA test for colorectal
cancer screening. Med Lett Drugs Ther 2025; 67:73.
9. TR Church et ...
The FDA has approved Shield (Guardant), a DNA
blood test, for colorectal cancer (CRC) screening
in average-risk adults ≥45 years old. Shield is the
second blood-based DNA test to be approved for CRC
screening; ColoHealth (formerly Epi proColon) was
approved in 2016.
Med Lett Drugs Ther. 2025 Jun 9;67(1730):90-2 doi:10.58347/tml.2025.1730b | Show Introduction Hide Introduction